Authors: Parra, HS Tixi, L Latteri, F Bretti, S Alloisio, M Gravina, A Lionetto, R Bruzzi, P Dani, C Rosso, R Cosso, M Balzarini, L Santoro, A Ardizzoni, A

Citation: Hs. Parra et al., Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP), CANCER, 92(3), 2001, pp. 650-656